Hyperglycemic Ins2AkitaLdlr⁻/⁻ mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease.
about
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesExperimental Diabetes Mellitus in Different Animal ModelsMolecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.IKKβ links vascular inflammation to obesity and atherosclerosisThe use of animal models in diabetes research.Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice.Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ miceIntestinal pregnane X receptor links xenobiotic exposure and hypercholesterolemia.Polydatin Restores Endothelium-Dependent Relaxation in Rat Aorta Rings Impaired by High Glucose: A Novel Insight into the PPARβ-NO Signaling Pathway.Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.Animal models of atherosclerosis.Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammationNuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver.Pregnane X receptor mediates dyslipidemia induced by the HIV protease inhibitor amprenavir in mice.Myeloid-specific IκB kinase β deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice.Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.Molecular biology of atherosclerosis.Unravelling the stromal-nerve interactions in the human diabetic cornea.Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.Diabetic aggravation of stroke and animal models.B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation.Pathogenesis of Type 1 Diabetes Mellitus and Rodent Experimental Models.
P2860
Q26822630-65BE3AA5-EE4E-49A2-AB02-749C2A49C989Q28066824-2017354F-8992-4BFC-88AE-8C89DC505BF7Q28070313-3497FE2E-266E-4129-9562-D0478328F23AQ33569809-22467F6A-3A4C-4D08-AA63-B007791A215EQ34255921-42E16575-DEB8-4545-AD92-B242E4C0D4D3Q34297158-779C9B1A-1B1D-4206-A89D-B49B541CFB92Q34513915-93A4B684-E4C0-46FB-AAE8-D6C597FADB06Q35555694-08430430-98D3-49AC-AEBD-C18AF26F8443Q35571583-806AEDE2-2F74-4CAB-A4B6-8D8E82B8638EQ35830289-B908CB54-48A9-4608-A826-B7EB685DFB74Q35903298-2CFAE4E2-3331-4328-B300-E28E0276B4E8Q36658372-D09F58EB-828C-4E74-A3C6-B29B3E8A1C2CQ36824716-90CF6F9E-92D9-4AA0-B34C-6CF25F557B02Q36852528-55B052F4-967A-4796-A9CD-662A0D0768C9Q37691504-3B826824-9714-47BA-9FB1-713581427AE6Q38059912-6439D934-3B6E-411C-BA65-4D52EF598970Q38125279-C0C1CB40-1DE7-4D61-BFBA-54A545144DD1Q38615682-3C73980A-AB59-4A5D-8BC0-EDA32A8574BAQ39071314-45CECDE0-0843-4F88-9613-FC0DECC9DC32Q39169261-890BEC5D-C253-4382-BE94-3BCD31C14B32Q51594134-F63D09ED-AF91-42F3-8380-D1DC2A34BFE9Q54945190-4B3B4F50-783F-4BC0-8989-B9A08219850C
P2860
Hyperglycemic Ins2AkitaLdlr⁻/⁻ mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hyperglycemic Ins2AkitaLdlr⁻/⁻ ...... iabetic macrovascular disease.
@ast
Hyperglycemic Ins2AkitaLdlr⁻/⁻ ...... iabetic macrovascular disease.
@en
type
label
Hyperglycemic Ins2AkitaLdlr⁻/⁻ ...... iabetic macrovascular disease.
@ast
Hyperglycemic Ins2AkitaLdlr⁻/⁻ ...... iabetic macrovascular disease.
@en
prefLabel
Hyperglycemic Ins2AkitaLdlr⁻/⁻ ...... iabetic macrovascular disease.
@ast
Hyperglycemic Ins2AkitaLdlr⁻/⁻ ...... iabetic macrovascular disease.
@en
P2093
P2860
P356
P1476
Hyperglycemic Ins2AkitaLdlr⁻/⁻ ...... iabetic macrovascular disease.
@en
P2093
Brian Pridgen
Jan L Breslow
Jinxian Xu
Nakesha King
P2860
P304
P356
10.1194/JLR.M014092
P577
2011-05-23T00:00:00Z